Cancer Genetic and Genomic TestingApply
Co-Pay Relief Program Fund Notices
Would you like to be notified when any new funds open, or when any of our current funds re-open? If so, please sign up using the “Get Notified” link below. As a member of our subscriber community you will receive important news about all of our disease funds, so join today!
Co-pay, Co-Insurance & DeductibleMaximum Award Level
$250 Per Year
- Household Income Requirements 400% or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
- Insurance Requirements All Insurance Types
- Must reside and receive treatment in the United States.
About Cancer Genetic and Genomic Testing
What the Fund Covers
This fund is intended to cover the cost of physician prescribed Genetic and Genomic tests for cancer. Covered tests are genetic tests to determine the risk of developing cancer based on heredity and genomic testing to diagnose cancer, identify mutation, determine treatment and monitor cancer growth. The fund does not cover procedures to get sample tissues, x-rays, MRIs, or scans/lab work outside of genetic and genomic tests. The fund also does not cover direct to consumer tests not prescribed by a physician.
Information About the Tests
Genetics is the study of single genes and their role in the way traits or conditions are passed from one generation to the next. Genetic alterations can be inherited from one’s parents, caused by environmental factors, or occur during natural processes such as cell division, and account for 90 to 95 percent of all cases of cancer. Genetic testing involves looking at the specific inherited changes or mutations in the chromosomes, genes or proteins that humans are born with and their role in the ways traits or conditions are passed from one generation to the next. Genetic testing can also be used to examine mutations that have been acquired in genes after birth.
Cancer is a group of diseases caused by changes in DNA that alter cell behavior, causing uncontrollable growth and malignancy. These abnormalities can take many forms, including DNA mutations, rearrangements, deletions, amplifications, and the addition or removal of chemical marks.
Genomics describes the study of all parts of an organism’s genes. Genomic tumor testing can tell one type of cancer or subtype of the cancer from another, identify the DNA alterations that are driving the growth of a particular tumor, as well as gain a better understanding of the molecular basis of cancer growth, metastasis, and/or drug resistance. Precision medicine uses the specific information about the tumor to help diagnose, select optimal therapies based on the context of the patient’s genetic profile, determine how well a treatment is working or make a prognosis.
- Good Days877-968-7233
- Healthwell Foundation800-675-8416
- Leukemia & Lymphoma Society800-955-4572
- National Organization for Rare Disorders800-999-6673
- Needy Meds800-503-6897
- Patient Access Network Foundation866-316-7263
- Patient Services Inc.800-366-7741
- The Assistance Fund855-845-3663